Mitrev, N., Vande Casteele, N., Corte, C., Ghaly, S., Lemberg, D. A., Kariyawasam, V., Lewindon, P., Martin, J., Mountifield, R., Radford-Smith, G., Slobodian, P., Sparrow, M., Seow, C. H., , , , , , Andrews, J. M., Connor, S. J., Moore, G. T., Barclay, M., Begun, J., Bryant, R., Chan, W.. Wiley-Blackwell; 2017. Review article: consensus statements on therapeutic drug monitoring of anti-tumour necrosis factor therapy in inflammatory bowel diseases.

Pilichiewicz, A. N., Andrews, J. M., Goess, C., McMahon, J., Fraser, R. J., Beilby, J., Holloway, R. H., Talley, N. J., Holtmann, G.. Wiley-Blackwell Publishing; 2011. A preliminary analysis of the effect Iberogast, Nexium, dual Iberogast + Nexium or dual placebo on symptoms in patients with functional dyspepsia.